HOXB2 as a novel prognostic indicator for stage I lung adenocarcinomas

Journal of Thoracic Oncology

Volumn 2, Issue 9, 2007, Pages 802-807

  Inamura, Kentauro ^a   Togashi, Yuki ^a   Okui, Michiyo ^a   Ninomiya, Hironori ^a   Hiramatsu, Miyako ^a   Satoh, Yukitoshi ^a,c   Okumura, Sakae ^c   Nakagawa, Ken ^c   Shimoji, Takashi ^b   Noda, Tetsuo ^a   Ishikawa, Yuichi ^a  

^a CANCER INSTITUTE   (Japan)

^b Genome Center   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

HOXB2; Lung adenocarcinoma; Prognostic indicator; Real time RT PCR

Indexed keywords

HOX PROTEIN; HOXB2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GENE; UPREGULATION;

ADENOCARCINOMA; CELL DIFFERENTIATION; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TRANSCRIPTION FACTORS;

EID: 34548426876     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181461987     Document Type: Article

References (26)

1. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717.
2. Miyoshi T, Satoh Y, Okumura S, et al. Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol 2003;27:101-109.
3. Inamura K, Shimoji T, Ninomiya H, et al. A metastatic signature in entire lung adenocarcinomas irrespective of morphological heterogeneity. Hum Pathol 2007;38:702-709.
4. Gehring WJ, Hiromi Y. Homeotic genes and the homeobox. Annu Rev Genet 1986;20:147-173.
5. Kikuchi T, Daigo Y, Katagiri T, et al. Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 2003;22:2192-2205.
6. Raz DJ, He B, Rosell R, et al. Current concepts in bronchioloalveolar carcinoma biology. Clin Cancer Res 2006;12:3698-3704.
7. Christiani DC, Pao W, DeMartini JC, et al. BAC consensus conference, November 4-6, 2004: epidemiology, pathogenesis, and preclinical models. J Thorac Oncol 2006;1:S2-S7.
8. Wislez M, Beer DG, Wistuba I, et al. Molecular biology, genomics, and proteomics in bronchioloalveolar carcinoma. J Thorac Oncol 2006;1:S8-S12.
9. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002;122:1037-1057.
10. Singhal S, Vachani A, Antin-Ozerkis D, et al. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res 2005;11:3974-3986.
11. D'Amico TA, Massey M, Herndon JE, 2nd, et al. A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers. J Thorac Cardiovasc Surg 1999;117:736-743.
12. Soria JC, Jang SJ, Khuri FR, et al. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 2000;60:4000-4004.
13. Potti A, Mukherjee S, Petersen R, et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-580.
14. Grier DG, Thompson A, Kwasniewska A, et al. The pathophysiology of HOX genes and their role in cancer. J Pathol 2005;205:154-171.
15. Apiou F, Flagiello D, Cillo C, et al. Fine mapping of human HOX gene clusters. Cytogenet Cell Genet 1996;73:114-115.
16. Krumlauf R. Hox genes in vertebrate development. Cell 1994;78:191-201.
17. Takahashi Y, Hamada J, Murakawa K, et al. Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid cancer cell lines by quantitative real-time RT-PCR system. Exp Cell Res 2004;293:144-153.
18. Golpon HA, Geraci MW, Moore MD, et al. HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol 2001;158:955-966.
19. Hatano M, Roberts CW, Minden M, et al. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science 1991;253:79-82.
20. Cillo C, Barba P, Freschi G, et al. HOX gene expression in normal and neoplastic human kidney. Int J Cancer 1992;51:892-897.
21. De Vita G, Barba P, Odartchenko N, et al. Expression of homeobox-containing genes in primary and metastatic colorectal cancer. Eur J Cancer 1993;29A:887-893.
22. Naora H, Yang YQ, Montz FJ, et al. A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells. Proc Natl Acad Sci U S A 2001;98:4060-4065.
23. Cantile M, Pettinato G, Procino A, et al. In vivo expression of the whole HOX gene network in human breast cancer. Eur J Cancer 2003;39:257-264.
24. Miyazaki YJ, Hamada J, Tada M, et al. HOXD3 enhances motility and invasiveness through the TGF-beta-dependent and -independent pathways in A549 cells. Oncogene 2002;21:798-808.
25. Lechner JF, Wang Y, Siddiq F, et al. Human lung cancer cells and tissues partially recapitulate the homeobox gene expression profile of embryonic lung. Lung Cancer 2002;37:41-47.
26. Segara D, Biankin AV, Kench JG, et al. Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clin Cancer Res 2005;11:3587-3596.